3 Jul 2020
EUR 60 million
Financial institutions and SMEs
|Date of agreement:||14 Dec 2017|
|Customer:||William Demant A/S|
|Amount in DKK:||DKK 400 million|
|Amount in EUR:||EUR 53.74 million|
|NACE sector / loan type:||Research and development|
|Business area:||Industries and services|
The loan has been provided to finance William Demant’s R&D investments in 2017.
The company’s ongoing R&D focuses on developing new innovations in hearing healthcare. William Demant is also working in close cooperation with several universities and research centres, as well as the corporate sector, to advance its technology and products.
This is the second loan agreement between NIB and William Demant; the first was signed in 2015.
William Demant Holding A/S is a global leader in hearing healthcare solutions, headquartered in Denmark. The company’s product range includes hearing devices, diagnostic instruments, hearing implants and devices for personal communication.
William Demant has a share of approximately 23% of the global hearing devices market, and is an R&D-intensive company. Global demand for hearing devices is increasing due to demographic developments and better diagnostics. Recent technological and digital developments, including wireless technology and the Internet of Things, are offering new opportunities for manufacturers of hearing aids, hearing implants and diagnostic instruments that result in increased benefits for the end users. The research is mainly carried out in Denmark, as well as in Poland, Switzerland and France.
No significant environmental issues have been identified.